We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Kirsty
Winkley
kirsty.winkley@kcl.ac.uk
Kirsty
Winkley
kirsty.winkley@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Diabetes mellitus
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
One in three persons affected by type 1 diabetes (T1D) report elevated psychological distress, a condition that complicates both daily living and diabetes self-management. Although diabetes distress is associated with elevated HbA1c levels and a higher risk of adverse diabetes-related health complications, people with T1D often have limited access to mental health services. E-mental health, which has advanced significantly in recent years, offers a potential solution. However, while there is an abundance of glucose and lifestyle focused apps (particularly for type 2 diabetes), there is a paucity of digital tools focusing on mental health for T1D. To fill this gap, researchers developed MyDiaMate, a web-based, self-guided programme grounded in principles of Cognitive Behavioural Therapy (CBT). The programme offers several modules centred around common sources of diabetes distress, including the disruptive impact of stress on blood glucose, fear of hypoglycaemia, disordered eating, and fatigue.
This randomized controlled trial seeks to determine the effectiveness of MyDiaMate in adults with T1D across the UK, the Netherlands, Spain, and Germany, specifically assessing improvement of mental health in terms of diabetes distress relative to care as usual (CAU). Adults with T1D and mild to moderate levels of diabetes-related distress will be eligible to participate and will be recruited through diabetes healthcare professionals at Guy's and St Thomas' Hospital NHS Foundation Trust and via social media. Eligible participants will complete three rounds of online, self-reported mental health measurements over six months. Those in the CAU group who wish to do so will be given access to MyDiaMate at the end of the third month. If found effective in the clinical trial, our ultimate aim is to make MyDiaMate widely available in English, Dutch, Spanish, and German, creating the opportunity to assist large groups of adults with T1D in self-managing diabetes distress and improving their mental health.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Psychological & Behavioural;
You can take part if:
You may not be able to take part if:
A participant would be considered ineligible for participation if they meet any of the following criteria: 1) have been diagnosed with a psychiatric disorder (e.g., depressive disorder, anxiety disorder, schizophrenia, bipolar disorder, post-traumatic stress disorder, personality disorder) in the past 6 months for which they are under psychiatric/psychological treatment; 2) suicidality; 3) do not read and speak English, as this will affect their ability to use MyDiaMate and the validity of the data collection tools (specifically, the questionnaires) 4) experience of cognitive problems that hamper using MyDiaMate; 5) prior use of MyDiaMate; and 6) active involvement in another behavioural intervention study.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Kirsty
Winkley
kirsty.winkley@kcl.ac.uk
Kirsty
Winkley
kirsty.winkley@kcl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST and funded by JUVENILE DIABETES RESEARCH FOUNDATION LIMITED .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 64087
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
